Identification of the human cDNA for new survival/evasion peptide (DSEP): Studies in vitro and in vivo of overexpression by neural cells

Experimental Neurology

Volumn 177, Issue 1, 2002, Pages 32-39

  Cunningham, Timothy J ^a   Jing, Huiyan ^a   Akerblom, Ingrid ^b   Morgan, Rod ^c   Fisher, Timothy S ^c   Neveu, Mark ^c  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b Department of Life Sciences   (United States)

^c PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

Calreticulin; Retinoic acid; Survival peptide; Xenotransplantation

Indexed keywords

COMPLEMENTARY DNA; DIFFUSIBLE SURVIVAL EVASION PEPTIDE; PEPTIDE DERIVATIVE; RETINOIC ACID; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; BRAIN; CANCER CELL; CELL CULTURE; CELL DIFFERENTIATION; CELL LINE; CELL SURVIVAL; CONTROLLED STUDY; DNA MODIFICATION; DNA PURIFICATION; GENE IDENTIFICATION; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; IMMUNOSUPPRESSIVE TREATMENT; MACROPHAGE; MACROPHAGE ACTIVATION; NERVE CELL; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; STREPTOCOCCUS; XENOGRAFT;

EID: 0036435645     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.2002.7979     Document Type: Article

References (30)

1. Basu, S., R. J. Binder, T. Ramalingam, and P. K. Srivastava. 2001. CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin. Immunity 14: 303-313.
2. Collins, S. J. 1987. The HL-60 promyelocytic leukemia cell line: Proliferation, differentiation, and cellular oncogene expression. Blood 70: 1233-1244.
3. Corcoran, J., and M. Maden. 1999. Nerve growth factor acts via retinoic acid synthesis to stimulate neurite outgrowth. Nature Neurosci. 2: 307-308.
4. Cunningham, T. J., L. Hodge, D. Speicher, D. Reim, C. Tyler-Polsz, P. Levitt, K. Eagleson, S. Kennedy, and Y. Wang. 1998. Identification of a survival-promoting peptide in medium conditioned by oxidatively stressed cell lines of nervous system origin. J. Neurosci. 18: 7047-7060.
5. Cunningham, T. J., H. Jing, Y. Wang, and L. Hodge. 2000. Calreticulin binding and other biological activities of survival peptide Y-P30 including effects of systemic treatment of rats. Exp. Neurol. 163: 457-468.
6. Dedhar, S., P. S. Rennie, M. Shago, C. Y. Hagesteijn, H. Yang, J. Filmus, R. G. Hawley, N. Bruchovsky, H. Cheng, and R. J. Matusik. 1994. Inhibition of nuclear hormone receptor activity by calreticulin. Nature 367: 480-483.
7. DeLuca, L. M. 1991. Retinoids and their receptors in differentiation, embryogenesis and neoplasia. FASEB J. 5: 2924-2933.
8. Desai, D., M. Michalak, N. K. Singh, and R. M. Niles. 1996. Inhibition of retinoic acid receptor function and retinoic acid-regulated gene expression in mouse melanoma cells by calreticulin. A potential pathway for cyclic AMP regulation of retinoid action. J. Biol. Chem. 271: 15153-15159.
9. Duan, W. M., M. Westerman, T. Flores, and W. C. Low. 2001. Survival of intrastriatal xenografts of ventral mesencephalic dopamine neurons from MHC-deficient mice to adult rats. Exp. Neurol. 167: 108-117.
10. Fabrizi, C., R. Businaro, G. M. Lauro, and L. Fumagalli. 2001. Role of alpha2-macroglobulin in regulating amyloid beta-protein neurotoxicity: Protective or detrimental factor? J. Neurochem. 78: 406-412.
11. Finsen, B. R., T. Sorensen, B. Castellano, E. M. Pedersen, and J. Zimmer. 1991. Leukocyte infiltration and glial reactions in xenografts of mouse brain tissue undergoing rejection in the adult rat brain. A light and electron microscopical immunocytochemical study. J. Neuroimmunol. 32: 159-183.
12. Hall, R. E., A. V. Muchmore, J. M. Decker, and R. M. Blaese. 1983. Induction of cytotoxic effector activity in the HL-60 promyelocytic cell line by incubation with phorbol myristate acetate: A model system of human spontaneous monocyte-mediated cytotoxicity. Cell. Immunol. 76: 58-68.
13. Imaizumi, T., K. L. Lankford, W. V. Burton, W. L. Fodor, and J. D. Kocsis. 2000. Xenotransplantation of transgenic pig olfactory ensheathing cells promotes axonal regeneration in rat spinal cord. Nature Biotechnol. 18: 949-953.
14. Jayadev, S., B. Liu, A. E. Bielawska, J. Y. Lee, F. Nazaire, Yu M. Pushkareva, L. M. Obeid, and Y. A. Hannun. 1995. Role for ceramide in cell cycle arrest. J. Biol. Chem. 270: 2047-2052.
15. Johnson, S., M. Michalak, M. Opas, and P. Eggleton. 2001. The ins and outs of calreticulin: From the ER lumen to the extracellular space. Trends Cell. Biol. 11: 122-129.
16. Kuwabara, K., D. J. Pinsky, A. M. Schmidt, C. Benedict, J. Brett, S. Ogawa, M. J. Broekman, A. J. Marcus, R. R. Sciacca, M. Michalak, et al. 1995. Calreticulin, an antithrombotic agent which binds to vitamin K-dependent coagulation factors, stimulates endothelial nitric oxide production, and limits thrombosis in canine coronary arteries. J. Biol. Chem. 270: 8179-8187.
17. Lee, H. J., D. N. Hammond, T. H. Large, J. D. Roback, J. A. Sim, D. A. Brown, U. H. Otten, and B. H. Wainer. 1990. Neuronal properties and trophic activities of immortalized hippocampal cells from embryonic and young adult mice. J. Neurosci. 10: 1779-1787.
18. Liu, Y., M. O. Lee, H. G. Wang, Y. Li, Y. Hashimoto, M. Klaus, J. C. Reed, and X. Zhang. 1996. Retinoic acid receptor β mediates the growth-inhibitory effect of retinoic acid by promoting apoptosis in human breast cancer cells. Mol. Cell. Biol. 16: 1138-1149.
19. Muriel, M. P., N. Lambeng, F. Darios, P. P. Michel, E. C. Hirsch, Y. Agid, and M. Ruberg. 2000. Mitochondrial free calcium levels (Rhod-2 fluorescence) and ultrastructural alterations in neuronally differentiated PC12 cells during ceramide-dependent cell death. J. Comp. Neurol. 426: 297-315.
20. Nakashima, H., K. Kawamura, and I. Date. 1988. Immunological reaction and blood-brain barrier in mouse-to-rat cross-species neural graft. Brain Res. 475: 232-243.
21. Niles, R. M. 1998. Control of retinoid nuclear receptor function and expression. In Subcellular Biochemistry, Vol. 30, Fat-Soluble Vitamins (Quinn and Kagan, Eds.), pp. 3-28. Plenum, New York.
22. Pollack, I. F., and R. D. Lund. 1990. The blood-brain barrier protects foreign antigens in the brain from immune attack. Exp. Neurol. 108: 114-121.
23. Schittek, B., R. Hipfel, B. Sauer, J. Bauer, H. Kalbacher, S. Stevanovic, M. Schirle, K. Schroeder, N. Blin, F. Meier, G. Rassner, and C. Garbe. 2001. Dermcidin: A novel human antibiotic peptide secreted by sweat glands. Nature Immunol. 2: 1133-1137.
24. Shago, M., G. Flock, C. Y. Leung Hagesteijn, M. Woodside, S. Grinstein, V. Giguere, and S. Dedhar. 1997. Modulation of the retinoic acid and retinoid X receptor signaling pathways in P19 embryonal carcinoma cells by calreticulin. Exp. Cell Res. 230: 50-60.
25. Solary, E., R. Bertrand, and Y. Pommier. 1994. Apoptosis of human leukemic HL-60 cells induced to differentiate by phorbol ester treatment. Leukemia 8: 792-797.
26. Sun S. Y., H. Wan, P. Yue, W. K. Hong, and R. Lotan. 2000. Evidence that retinoic acid receptor beta induction by retinoids is important for tumor cell growth inhibition. J. Biol. Chem. 275: 17149-17153.
27. Takahashi, J., T. D. Palmer, and F. H. Gage. 1999. Retinoic acid and neurotrophins collaborate to regulate neurogenesis in adult-derived neural stem cell cultures. J. Neurobiol. 38: 65-81.
28. Todorov, P., P. Cariuk, T. McDevitt, B. Coles, K. Fearon, and M. Tisdale. 1996. Characterization of a cancer cachectic factor. Nature 379: 739-742.
29. Toulouse, A., M. Loubeau, J. Morin, J. J. Pappas, J. Wu, and W. E. Bradley. 2000. RARβ involvement in enhancement of lung tumor cell immunogenicity revealed by array analysis. FASEB J. 14: 1224-1232.
30. Yoshizawa, N., S. Oshima, I. Sagel, J. Shimizu, and G. Treser. 1992. Role of a streptococcal antigen in the pathogenesis of acute poststreptococcal glomerulonephritis. Characterization of the antigen and a proposed mechanism for the disease. J. Immunol. 148: 3110-63116.